Back to Trades
Total Value
$0
Filing Date
Mar 17, 2026
1 transaction
Trade Summary
On Mar 1, 2026, Zosel Andrew Joseph, EVP, Chief Prod & Tech Officer, reported $0 of DIEBOLD NIXDORF, Inc (DBD) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- DIEBOLD NIXDORF, Inc
- Ticker Symbol
- DBD
- CIK
- 0000028823
Insider Information
- Role
- EVP, Chief Prod & Tech Officer
- Location
- NORTH CANTON, OH
Filing Details
- Filing Date
- Mar 17, 2026
- Transaction Date
- Mar 1, 2026
- Accession Number
- 0002121521-26-000003
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 1, 2026 | Common Stock | 6,561 | — | Grant/Award | — |
Want live alerts when Zosel Andrew Joseph trades again?
Download Insider Trades to track DBD, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Award of Restricted Stock Units granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended, and vesting in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant; each Restricted Stock Unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock.
- (F2)Number includes Restricted Stock Units.